ID   SDC1_HUMAN              Reviewed;         310 AA.
AC   P18827; D6W523; Q53QV0; Q546D3; Q96HB7;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Syndecan-1;
DE            Short=SYND1;
DE   AltName: CD_antigen=CD138;
DE   Flags: Precursor;
GN   Name=SDC1; Synonyms=SDC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-136.
RC   TISSUE=Fibroblast;
RX   PubMed=1339431;
RA   Lories V., Cassiman J.-J., van de Berghe H., David G.;
RT   "Differential expression of cell surface heparan sulfate proteoglycans
RT   in human mammary epithelial cells and lung fibroblasts.";
RL   J. Biol. Chem. 267:1116-1122(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-136.
RC   TISSUE=Mammary gland;
RX   PubMed=2324102;
RA   Mali M., Jaakkola P., Arvilommi A.-M., Jalkanen M.;
RT   "Sequence of human syndecan indicates a novel gene family of integral
RT   membrane proteoglycans.";
RL   J. Biol. Chem. 265:6884-6889(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-136.
RX   PubMed=15177497; DOI=10.1016/j.ejca.2004.01.038;
RA   Mennerich D., Vogel A., Klaman I., Dahl E., Lichtner R.B.,
RA   Rosenthal A., Pohlenz H.D., Thierauch K.H., Sommer A.;
RT   "Shift of syndecan-1 expression from epithelial to stromal cells
RT   during progression of solid tumours.";
RL   Eur. J. Cancer 40:1373-1382(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-136.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-136.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 23-310, AND VARIANT GLN-136.
RC   TISSUE=Placenta;
RX   PubMed=9050911; DOI=10.1007/s004390050360;
RA   Kaukonen J., Alanen-Kurki L., Jalkanen M., Palotie A.;
RT   "The mapping and visual ordering of the human syndecan-1 and N-myc
RT   genes near the telomeric region of chromosome 2p.";
RL   Hum. Genet. 99:295-297(1997).
RN   [8]
RP   SHEDDING, AND SUBCELLULAR LOCATION.
RX   PubMed=9169435; DOI=10.1074/jbc.272.23.14713;
RA   Subramanian S.V., Fitzgerald M.L., Bernfield M.;
RT   "Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and
RT   growth factor receptor activation.";
RL   J. Biol. Chem. 272:14713-14720(1997).
RN   [9]
RP   INTERACTION WITH CDCP1.
RX   PubMed=16007225; DOI=10.1038/sj.onc.1208582;
RA   Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.;
RT   "Adhesion signaling by a novel mitotic substrate of src kinases.";
RL   Oncogene 24:5333-5343(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 303-310 IN COMPLEX WITH
RP   TIAM1, AND INTERACTION WITH TIAM1.
RX   PubMed=23395182; DOI=10.1016/j.str.2013.01.004;
RA   Liu X., Shepherd T.R., Murray A.M., Xu Z., Fuentes E.J.;
RT   "The structure of the Tiam1 PDZ domain/ phospho-syndecan1 complex
RT   reveals a ligand conformation that modulates protein dynamics.";
RL   Structure 21:342-354(2013).
CC   -!- FUNCTION: Cell surface proteoglycan that bears both heparan
CC       sulfate and chondroitin sulfate and that links the cytoskeleton to
CC       the interstitial matrix. Regulates exosome biogenesis in concert
CC       with SDCBP and PDCD6IP (PubMed:22660413).
CC       {ECO:0000269|PubMed:22660413}.
CC   -!- SUBUNIT: Interacts with CDCP1. Interacts (via C-terminus) with
CC       TIAM1 (via PDZ domain). {ECO:0000269|PubMed:16007225,
CC       ECO:0000269|PubMed:23395182}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass type I
CC       membrane protein {ECO:0000255}. Secreted
CC       {ECO:0000269|PubMed:9169435}. Secreted, exosome
CC       {ECO:0000269|PubMed:22660413}. Note=Shedding of the ectodomain
CC       produces a soluble form. {ECO:0000269|PubMed:9169435}.
CC   -!- PTM: Shedding is enhanced by a number of factors such as
CC       heparanase, thrombin or EGF. Also by stress and wound healing.
CC       PMA-mediated shedding is inhibited by TIMP3.
CC       {ECO:0000269|PubMed:9169435}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SDC1ID42223ch2p24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60306; CAA42851.1; -; mRNA.
DR   EMBL; J05392; AAA60605.1; -; mRNA.
DR   EMBL; AJ551176; CAD80245.1; -; mRNA.
DR   EMBL; AC104792; AAX93151.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00828.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00829.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00830.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00831.1; -; Genomic_DNA.
DR   EMBL; BC008765; AAH08765.1; -; mRNA.
DR   EMBL; Z48199; CAA88235.1; -; Genomic_DNA.
DR   CCDS; CCDS1697.1; -.
DR   PIR; A41776; A41776.
DR   RefSeq; NP_001006947.1; NM_001006946.1.
DR   RefSeq; NP_002988.3; NM_002997.4.
DR   UniGene; Hs.224607; -.
DR   UniGene; Hs.665958; -.
DR   PDB; 4GVC; X-ray; 1.54 A; B=303-310.
DR   PDB; 4GVD; X-ray; 1.85 A; C/D=303-310.
DR   PDBsum; 4GVC; -.
DR   PDBsum; 4GVD; -.
DR   ProteinModelPortal; P18827; -.
DR   SMR; P18827; -.
DR   BioGrid; 112284; 46.
DR   DIP; DIP-1123N; -.
DR   IntAct; P18827; 8.
DR   MINT; MINT-5004100; -.
DR   STRING; 9606.ENSP00000254351; -.
DR   TCDB; 9.A.35.1.2; the peptide translocating syndecan (syndecan) family.
DR   iPTMnet; P18827; -.
DR   PhosphoSitePlus; P18827; -.
DR   SwissPalm; P18827; -.
DR   BioMuta; SDC1; -.
DR   DMDM; 229463011; -.
DR   EPD; P18827; -.
DR   MaxQB; P18827; -.
DR   PaxDb; P18827; -.
DR   PeptideAtlas; P18827; -.
DR   PRIDE; P18827; -.
DR   DNASU; 6382; -.
DR   Ensembl; ENST00000254351; ENSP00000254351; ENSG00000115884.
DR   Ensembl; ENST00000381150; ENSP00000370542; ENSG00000115884.
DR   GeneID; 6382; -.
DR   KEGG; hsa:6382; -.
DR   UCSC; uc002rdo.2; human.
DR   CTD; 6382; -.
DR   DisGeNET; 6382; -.
DR   GeneCards; SDC1; -.
DR   H-InvDB; HIX0161948; -.
DR   HGNC; HGNC:10658; SDC1.
DR   HPA; CAB002424; -.
DR   HPA; HPA006185; -.
DR   MIM; 186355; gene.
DR   neXtProt; NX_P18827; -.
DR   OpenTargets; ENSG00000115884; -.
DR   PharmGKB; PA35588; -.
DR   eggNOG; ENOG410IYWX; Eukaryota.
DR   eggNOG; ENOG410Y2QY; LUCA.
DR   GeneTree; ENSGT00530000063116; -.
DR   HOGENOM; HOG000133092; -.
DR   HOVERGEN; HBG017783; -.
DR   InParanoid; P18827; -.
DR   KO; K06257; -.
DR   OMA; PTKQEEF; -.
DR   OrthoDB; EOG091G0EYV; -.
DR   PhylomeDB; P18827; -.
DR   TreeFam; TF320463; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   ChiTaRS; SDC1; human.
DR   GeneWiki; Syndecan_1; -.
DR   GenomeRNAi; 6382; -.
DR   PMAP-CutDB; P18827; -.
DR   PRO; PR:P18827; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115884; -.
DR   CleanEx; HS_SDC1; -.
DR   ExpressionAtlas; P18827; baseline and differential.
DR   Genevisible; P18827; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0001948; F:glycoprotein binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0048627; P:myoblast development; ISS:UniProtKB.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; IMP:UniProtKB.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; IMP:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0060009; P:Sertoli cell development; IEA:Ensembl.
DR   GO; GO:0055002; P:striated muscle cell development; IEP:UniProtKB.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR031190; Syndecan-1.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   PANTHER; PTHR10915:SF12; PTHR10915:SF12; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Glycoprotein; Heparan sulfate;
KW   Membrane; Phosphoprotein; Polymorphism; Proteoglycan;
KW   Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    310       Syndecan-1.
FT                                /FTId=PRO_0000033499.
FT   TOPO_DOM     23    254       Extracellular. {ECO:0000255}.
FT   TRANSMEM    255    275       Helical. {ECO:0000255}.
FT   TOPO_DOM    276    310       Cytoplasmic. {ECO:0000255}.
FT   SITE        242    243       Cleavage. {ECO:0000250}.
FT   MOD_RES     285    285       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     37     37       O-linked (Xyl...) (chondroitin sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     45     45       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD     47     47       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD    206    206       O-linked (Xyl...) (chondroitin sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD    216    216       O-linked (Xyl...) (chondroitin sulfate)
FT                                serine. {ECO:0000250}.
FT   VARIANT      76     76       T -> M (in dbSNP:rs2230922).
FT                                /FTId=VAR_052242.
FT   VARIANT     136    136       L -> Q (in dbSNP:rs10205485).
FT                                {ECO:0000269|PubMed:1339431,
FT                                ECO:0000269|PubMed:15177497,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2324102,
FT                                ECO:0000269|PubMed:9050911,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_052243.
FT   CONFLICT     19     19       P -> L (in Ref. 2; AAA60605).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       G -> V (in Ref. 6; AAH08765).
FT                                {ECO:0000305}.
FT   STRAND      305    309       {ECO:0000244|PDB:4GVC}.
SQ   SEQUENCE   310 AA;  32462 MW;  8E9EF4A57F5FDBD0 CRC64;
     MRRAALWLWL CALALSLQPA LPQIVATNLP PEDQDGSGDD SDNFSGSGAG ALQDITLSQQ
     TPSTWKDTQL LTAIPTSPEP TGLEATAAST STLPAGEGPK EGEAVVLPEV EPGLTAREQE
     ATPRPRETTQ LPTTHLASTT TATTAQEPAT SHPHRDMQPG HHETSTPAGP SQADLHTPHT
     EDGGPSATER AAEDGASSQL PAAEGSGEQD FTFETSGENT AVVAVEPDRR NQSPVDQGAT
     GASQGLLDRK EVLGGVIAGG LVGLIFAVCL VGFMLYRMKK KDEGSYSLEE PKQANGGAYQ
     KPTKQEEFYA
//
